Eli Lilly and Company

NYSE-LLY

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	9,791.9	3,375.9	3,093.3	3,268.4	3,369	3,223.6
Cash and Cash Equivalents
Short-Term Investments	121.6	170.1	127.4	154.8	149.4	140.4
Short-Term Investments
Total Cash and Cash Equivalents	9,913.5	3,546	3,220.7	3,423.2	3,518.4	3,364
Accounts Receivable	16,107.4	14,170.4	12,036.6	11,005.7	10,294.8	11,027.9
Accounts Receivable, Net
Other Receivables	3,349.8	3,035.2	1,966.6	2,269.7	1,756.9	2,051.1
Other Receivables
Total Trade Receivables	19,457.2	17,205.6	14,003.2	13,275.4	12,051.7	13,079
Inventories	12,180.4	11,013.8	9,311	7,589.2	7,459.8	6,481.5
Inventories
Other Current Assets	20,520.2	18,088.6	14,726.3	8,451.9	8,385.2	7,279.8
Prepaid Expenses and Other
Current Assets of Discontinued Operations
Prepaid Expenses
Other Current Assets
Total Current Assets	62,071.3	49,854	41,261.2	32,739.7	31,415.1	30,204.3
Total Current Assets
Net Property, Plant & Equipment	22,316	20,529.7	18,474.1	17,102.4	16,171.8	14,829.4
Property and Equipment, Net
Operating Lease Assets
Net Intangible Assets	6,446.7	5,908.3	6,012.2	6,166.3	6,537.3	6,636.1
Other Intangibles, Net
Goodwill	5,898	5,770.5	5,770.5	5,770.3	5,768.4	5,768.2
Goodwill
Long-Term Investments	2,808.3	3,207.4	3,222.7	3,215.9	3,200.2	2,877.6
Investments
Other Long-Term Assets	15,395.1	15,652.7	14,648.1	13,720.3	12,514.1	11,559.2
Deferred Tax Assets
Sundry
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	114,935.4	100,922.6	89,388.8	78,714.9	75,606.9	71,874.8
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	4,262.2	4,075.7	3,442	3,228.6	2,886.5	2,924.8
Accounts Payable
Accrued Expenses	1,965.7	1,303	1,113.9	2,093.9	1,703.3	1,168.3
Employee Compensation
Short-Term Debt	1,633	5,723.7	4,016.4	5,117.1	2,074.3	5,161.6
Short-Term Borrowings and Current Maturities of Long-Term Debt
Other Current Liabilities	32,280	27,917.5	21,495.8	17,937	18,010	17,866.5
Sales Rebates and Discounts
Dividends Payable
Short-Term Income Taxes Payable
Deferred Income Taxes
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	40,140.9	39,019.9	30,068.1	28,376.6	24,674.1	27,121.2
Total Current Liabilities
Long-Term Debt	40,873.6	34,180.1	34,499.5	28,527.1	29,045.4	23,730.4
Long-Term Debt
Leases	—	—	—	—	—	—
Noncurrent Operating Lease Liabilities
Other Long-Term Liabilities	10,070.1	9,373.5	8,974.4	7,539.6	7,566.7	7,387.7
Accrued Retirement Benefits
Long-Term Income Taxes Payable
Deferred Tax Liabilities
Noncurrent Liabilities of Discontinued Operations
Other Noncurrent Liabilities
Total Long-Term Liabilities	50,943.7	43,553.6	43,473.9	36,066.7	36,612.1	31,118.1
Total Noncurrent Liabilities
Total Liabilities	91,084.6	82,573.5	73,542	64,443.3	61,286.2	58,239.3

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Common Stock	591.4	592	592.6	592.4	593.9	594.2
Common Stock
Treasury Stock	-62.5	-55.4	-49.5	-49.5	-32.7	-32.7
Cost of Common Stock in Treasury
Additional Paid-in Capital	7,231.9	7,089.3	6,910	7,439.3	7,339.6	7,214.2
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-6,219.5	-6,729.2	-6,787.8	-7,335.1	-7,288	-7,391.7
Accumulated Other Comprehensive Loss
Employee Benefit Trust
Retained Earnings	22,252	17,376.2	15,099.5	13,545	13,627.2	13,178
Retained Earnings
Total Common Shareholders' Equity	23,793.3	18,272.9	15,764.8	14,192.1	14,240	13,562
Total Eli Lilly and Company Shareholders' Equity
Minority Interests and Other	57.5	76.2	82	79.5	80.7	73.5
Noncontrolling Interests
Total Shareholders' Equity	23,850.8	18,349.1	15,846.8	14,271.6	14,320.7	13,635.5
Total Equity
Total Liabilities and Shareholders' Equity	114,935.4	100,922.6	89,388.8	78,714.9	75,606.9	71,874.8
Total Liabilities and Equity